British cyclist Chris Froome to cooperate with UCI after abnormal drug test

Image
IANS Madrid
Last Updated : Dec 13 2017 | 4:30 PM IST

Britain's four-time Tour de France champion Chris Froome on Wednesday said he would provide any information required by the International Cycling Union, the sport's world governing body, after twice the permitted dosage of an asthma drug was found in a urine sample he provided during this year's Vuelta a España.

Under World Anti-Doping Agency rules, riders must restrict levels of Salbutamol, commonly found in inhalers used by asthmatics, to 1000 nanograms per milliliter but a test taken by the 32-year-old Team Sky cyclist towards the end of the 2017 Vuelta, which he went on to win, revealed almost double that concentration, meaning that he has to explain the finding to the union (UCI) as per its anti-doping guidelines, reports Efe.

"It is well known that I have asthma and I know exactly what the rules are," Froome said in a statement released via Team Sky. "I use an inhaler to manage my symptoms (always within the permissible limits) and I know for sure that I will be tested every day I wear the race leader's jersey," he added.

He said his asthma symptoms grew worse at the Vuelta and he increased his intake of Salbutamol on doctor's orders, all the while ensuring he restricted his dosage to permissible levels.

"I take my leadership position in my sport very seriously," Froome said. "The UCI is absolutely right to examine test results and, together with the team, I will provide whatever information it requires," he concluded.

Team Sky manager Sir Dave Brailsford said he was confident that the Kenyan-born British cyclist followed WADA guidelines and that the team was committed to establishing why the test showed such a high dosage, adding that the secretion of Salbutamol entailed complicated medical and physiological issues.

None of the other 20 test samples provided by Froome required further explanation to the UCI.

Olympic bronze medallist Froome has become a dominant force in the world of cycling, with four Tour de France general classifications to his name -- three consecutively and a double -- Tour de France-Vuelta in 2017.

--IANS

sam/bg

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Dec 13 2017 | 4:24 PM IST

Next Story